Mesenchymal Stem Cells, Extracellular Vesicles, and Transcranial Magnetic Stimulation for Ferroptosis After Spinal Cord Injury

Overview

Journal Neural Regen Res

Date 2023 Mar 17

PMID 36926700

Authors

Qi-Feng Song

Qian Cui

Ya-Shi Wang

Li-Xin Zhang

Affiliations

Soon will be listed here.

Abstract

Spinal cord injury is characterized by different aetiologies, complex pathogenesis, and diverse pathological changes. Current treatments are not ideal, and prognosis is generally poor. After spinal cord injury, neurons die due to various forms of cell death. Among them, ferroptosis causes dysfunction after spinal cord injury, and no existing traditional treatments have been indicated to block its occurrence. Meanwhile, emerging therapies using mesenchymal stem cells, extracellular vesicles, and transcranial magnetic stimulation therapy are promising for reversing spinal cord neuronal ferroptosis after spinal cord injury. However, no definitive studies have demonstrated the effectiveness of these approaches. This review summarizes the existing research on the mechanisms of ferroptosis; ferroptosis after spinal cord injury; treatment of spinal cord injury with mesenchymal stem cells, extracellular vesicles, and transcranial magnetic stimulation; and treatment of ferroptosis using mesenchymal stem cells, extracellular vesicles, and transcranial magnetic stimulation. Inhibiting ferroptosis can promote the reversal of neurological dysfunction after spinal cord injury. In addition, mesenchymal stem cells, extracellular vesicles, and transcranial magnetic stimulation can reverse adverse outcomes of spinal cord injury and regulate ferroptosis-related factors. Thus, it can be inferred that mesenchymal stem cells, extracellular vesicles, and transcranial magnetic stimulation have the potential to inhibit ferroptosis after spinal cord injury. This review serves as a reference for future research to confirm these conclusions.

Citing Articles

Repetitive Transcranial Magnetic Stimulation for the Treatment of Spinal Cord Injury: Current Status and Perspective.

Fan S, Wang W, Zheng X Int J Mol Sci. 2025; 26(2).

PMID: 39859537 PMC: 11766194. DOI: 10.3390/ijms26020825.

Utilizing engineered extracellular vesicles as delivery vectors in the management of ischemic stroke: a special outlook on mitochondrial delivery.

Chen J, Li Y, Quan X, Chen J, Han Y, Yang L Neural Regen Res. 2024; 20(8):2181-2198.

PMID: 39101653 PMC: 11759020. DOI: 10.4103/NRR.NRR-D-24-00243.

Metabolic reprogramming: a new option for the treatment of spinal cord injury.

Chen J, Chen J, Yu C, Xia K, Yang B, Wang R Neural Regen Res. 2024; 20(4):1042-1057.

PMID: 38989936 PMC: 11438339. DOI: 10.4103/NRR.NRR-D-23-01604.

High-frequency repetitive transcranial magnetic stimulation promotes neural stem cell proliferation after ischemic stroke.

Luo J, Feng Y, Hong Z, Yin M, Zheng H, Zhang L Neural Regen Res. 2023; 19(8):1772-1780.

PMID: 38103244 PMC: 10960276. DOI: 10.4103/1673-5374.389303.

Functional near-infrared spectroscopy in non-invasive neuromodulation.

Huo C, Xu G, Xie H, Chen T, Shao G, Wang J Neural Regen Res. 2023; 19(7):1517-1522.

PMID: 38051894 PMC: 10883499. DOI: 10.4103/1673-5374.387970.

References

Liu A, Zhang X, He H, Zhou L, Naito Y, Sugita S . Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease. Expert Opin Biol Ther. 2019; 20(2):125-140. PMC: 6981051. DOI: 10.1080/14712598.2020.1689954. View

Anjum A, Yazid M, Daud M, Idris J, Ng A, Naicker A . Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms. Int J Mol Sci. 2020; 21(20). PMC: 7589539. DOI: 10.3390/ijms21207533. View

Gunduz A, Rothwell J, Vidal J, Kumru H . Non-invasive brain stimulation to promote motor and functional recovery following spinal cord injury. Neural Regen Res. 2018; 12(12):1933-1938. PMC: 5784334. DOI: 10.4103/1673-5374.221143. View

Dixon S, Lemberg K, Lamprecht M, Skouta R, Zaitsev E, Gleason C . Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012; 149(5):1060-72. PMC: 3367386. DOI: 10.1016/j.cell.2012.03.042. View

Li F, Wang H, Chen H, Guo J, Dang X, Ru Y . Mechanism of Ferroptosis and Its Role in Spinal Cord Injury. Front Neurol. 2022; 13:926780. PMC: 9218271. DOI: 10.3389/fneur.2022.926780. View

Lim W, Liau L, Ng M, Chowdhury S, Law J . Current Progress in Tendon and Ligament Tissue Engineering. Tissue Eng Regen Med. 2019; 16(6):549-571. PMC: 6879704. DOI: 10.1007/s13770-019-00196-w. View

Li L, Wang H, Zhang J, Chen X, Zhang Z, Li Q . Effect of endothelial progenitor cell-derived extracellular vesicles on endothelial cell ferroptosis and atherosclerotic vascular endothelial injury. Cell Death Discov. 2021; 7(1):235. PMC: 8423825. DOI: 10.1038/s41420-021-00610-0. View

Navarro de Lara L, Daneshzand M, Mascarenas A, Paulson D, Pratt K, Okada Y . A 3-axis coil design for multichannel TMS arrays. Neuroimage. 2020; 224:117355. PMC: 7837414. DOI: 10.1016/j.neuroimage.2020.117355. View

Lu J, Yang J, Zheng Y, Chen X, Fang S . Extracellular vesicles from endothelial progenitor cells prevent steroid-induced osteoporosis by suppressing the ferroptotic pathway in mouse osteoblasts based on bioinformatics evidence. Sci Rep. 2019; 9(1):16130. PMC: 6834614. DOI: 10.1038/s41598-019-52513-x. View

10.

Hu X, Chen H, Xu H, Wu Y, Wu C, Jia C . Role of Pyroptosis in Traumatic Brain and Spinal Cord Injuries. Int J Biol Sci. 2020; 16(12):2042-2050. PMC: 7294939. DOI: 10.7150/ijbs.45467. View

11.

Delarue Q, Robac A, Massardier R, Marie J, Guerout N . Comparison of the effects of two therapeutic strategies based on olfactory ensheathing cell transplantation and repetitive magnetic stimulation after spinal cord injury in female mice. J Neurosci Res. 2021; 99(7):1835-1849. PMC: 8359979. DOI: 10.1002/jnr.24836. View

12.

Wang J, Chen Y, Chen L, Duan Y, Kuang X, Peng Z . EGCG modulates PKD1 and ferroptosis to promote recovery in ST rats. Transl Neurosci. 2020; 11(1):173-181. PMC: 7712186. DOI: 10.1515/tnsci-2020-0119. View

13.

Wu S, Li T, Liu W, Huang Y . Ferroptosis and Cancer: Complex Relationship and Potential Application of Exosomes. Front Cell Dev Biol. 2021; 9:733751. PMC: 8455874. DOI: 10.3389/fcell.2021.733751. View

14.

Jiang Y, Guo J, Tang X, Wang X, Hao D, Yang H . The Immunological Roles of Olfactory Ensheathing Cells in the Treatment of Spinal Cord Injury. Front Immunol. 2022; 13:881162. PMC: 9163387. DOI: 10.3389/fimmu.2022.881162. View

15.

Lukomska B, Stanaszek L, Zuba-Surma E, Legosz P, Sarzynska S, Drela K . Challenges and Controversies in Human Mesenchymal Stem Cell Therapy. Stem Cells Int. 2019; 2019:9628536. PMC: 6481040. DOI: 10.1155/2019/9628536. View

16.

Fiani B, Arshad M, Shaikh E, Baig A, Farooqui M, Ayub M . Current updates on various treatment approaches in the early management of acute spinal cord injury. Rev Neurosci. 2021; 32(5):513-530. DOI: 10.1515/revneuro-2020-0148. View

17.

Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D . CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020; 19(1):43. PMC: 7045485. DOI: 10.1186/s12943-020-01168-8. View

18.

Park M, Cha H, Kim J, Kim J, Yang H, Yoon S . NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases. Redox Biol. 2021; 41:101947. PMC: 8027773. DOI: 10.1016/j.redox.2021.101947. View

19.

Lee J, Cha H, Park T, Park J . Enhanced osteogenic differentiation of human mesenchymal stem cells by direct delivery of Cbfβ protein. Biotechnol Bioeng. 2020; 117(9):2897-2910. DOI: 10.1002/bit.27453. View

20.

Guo S, Redenski I, Levenberg S . Spinal Cord Repair: From Cells and Tissue Engineering to Extracellular Vesicles. Cells. 2021; 10(8). PMC: 8394921. DOI: 10.3390/cells10081872. View